Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats

Tiziana Pascucci, Irene Cioli, Francesca Pisetzky, Silvestro Dupre, Alessandra Spirito, Paolo Nencini

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Acamprosate (calcium acetylhomotaurinate is a GABA derivative that prevents drinking relapses in a significant number of alcoholics. Since little is known about the interaction of acamprosate with other addictive drugs, we studied the effects of this agent (as sodium salt) in two groups of rats trained to discriminate, respectively, morphine (1.7 mg kg-1 i.p.) or amphetamine (0.5 mg kg-1 i.p.) from solvent in a two-lever fixed ratio 30 operant behaviour reinforced by water access. Accordingly to the finding that acamprosate inhibits the action of excitatory aminoacids, its effects were compared with those of dizocilpine (MK-801), an NMDA antagonist. Results show that acamprosate (170 and 320 mg kg-1 i.p.) produced a slight, and not significant, shift to the left of generalization curves of both morphine and amphetamine without affecting response rates. In contrast, MK-801 potentiated response rate effects of both morphine and amphetamine without affecting their generalization curves. As far as discriminative stimuli participate in the relapsing process of addiction, our results do not predict a role of acamprosate in the prevention of amphetamine or morphine abuse relapsing.

Original languageEnglish
Pages (from-to)333-338
Number of pages6
JournalPharmacological Research
Volume40
Issue number4
DOIs
Publication statusPublished - Oct 1999

Fingerprint

Amphetamine
Morphine
Dizocilpine Maleate
Amphetamine-Related Disorders
Morphine Dependence
N-Methylaspartate
Alcoholics
gamma-Aminobutyric Acid
Drinking
acamprosate
Salts
Sodium
Recurrence
Water
Pharmaceutical Preparations

Keywords

  • Acamprosate
  • D-amphetamins
  • Drug-discrimination
  • Morphine
  • Rat

ASJC Scopus subject areas

  • Pharmacology

Cite this

Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats. / Pascucci, Tiziana; Cioli, Irene; Pisetzky, Francesca; Dupre, Silvestro; Spirito, Alessandra; Nencini, Paolo.

In: Pharmacological Research, Vol. 40, No. 4, 10.1999, p. 333-338.

Research output: Contribution to journalArticle

Pascucci, Tiziana ; Cioli, Irene ; Pisetzky, Francesca ; Dupre, Silvestro ; Spirito, Alessandra ; Nencini, Paolo. / Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats. In: Pharmacological Research. 1999 ; Vol. 40, No. 4. pp. 333-338.
@article{332f01ff7bfd425499b76c31868aa727,
title = "Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats",
abstract = "Acamprosate (calcium acetylhomotaurinate is a GABA derivative that prevents drinking relapses in a significant number of alcoholics. Since little is known about the interaction of acamprosate with other addictive drugs, we studied the effects of this agent (as sodium salt) in two groups of rats trained to discriminate, respectively, morphine (1.7 mg kg-1 i.p.) or amphetamine (0.5 mg kg-1 i.p.) from solvent in a two-lever fixed ratio 30 operant behaviour reinforced by water access. Accordingly to the finding that acamprosate inhibits the action of excitatory aminoacids, its effects were compared with those of dizocilpine (MK-801), an NMDA antagonist. Results show that acamprosate (170 and 320 mg kg-1 i.p.) produced a slight, and not significant, shift to the left of generalization curves of both morphine and amphetamine without affecting response rates. In contrast, MK-801 potentiated response rate effects of both morphine and amphetamine without affecting their generalization curves. As far as discriminative stimuli participate in the relapsing process of addiction, our results do not predict a role of acamprosate in the prevention of amphetamine or morphine abuse relapsing.",
keywords = "Acamprosate, D-amphetamins, Drug-discrimination, Morphine, Rat",
author = "Tiziana Pascucci and Irene Cioli and Francesca Pisetzky and Silvestro Dupre and Alessandra Spirito and Paolo Nencini",
year = "1999",
month = "10",
doi = "10.1006/phrs.1999.0524",
language = "English",
volume = "40",
pages = "333--338",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
number = "4",

}

TY - JOUR

T1 - Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats

AU - Pascucci, Tiziana

AU - Cioli, Irene

AU - Pisetzky, Francesca

AU - Dupre, Silvestro

AU - Spirito, Alessandra

AU - Nencini, Paolo

PY - 1999/10

Y1 - 1999/10

N2 - Acamprosate (calcium acetylhomotaurinate is a GABA derivative that prevents drinking relapses in a significant number of alcoholics. Since little is known about the interaction of acamprosate with other addictive drugs, we studied the effects of this agent (as sodium salt) in two groups of rats trained to discriminate, respectively, morphine (1.7 mg kg-1 i.p.) or amphetamine (0.5 mg kg-1 i.p.) from solvent in a two-lever fixed ratio 30 operant behaviour reinforced by water access. Accordingly to the finding that acamprosate inhibits the action of excitatory aminoacids, its effects were compared with those of dizocilpine (MK-801), an NMDA antagonist. Results show that acamprosate (170 and 320 mg kg-1 i.p.) produced a slight, and not significant, shift to the left of generalization curves of both morphine and amphetamine without affecting response rates. In contrast, MK-801 potentiated response rate effects of both morphine and amphetamine without affecting their generalization curves. As far as discriminative stimuli participate in the relapsing process of addiction, our results do not predict a role of acamprosate in the prevention of amphetamine or morphine abuse relapsing.

AB - Acamprosate (calcium acetylhomotaurinate is a GABA derivative that prevents drinking relapses in a significant number of alcoholics. Since little is known about the interaction of acamprosate with other addictive drugs, we studied the effects of this agent (as sodium salt) in two groups of rats trained to discriminate, respectively, morphine (1.7 mg kg-1 i.p.) or amphetamine (0.5 mg kg-1 i.p.) from solvent in a two-lever fixed ratio 30 operant behaviour reinforced by water access. Accordingly to the finding that acamprosate inhibits the action of excitatory aminoacids, its effects were compared with those of dizocilpine (MK-801), an NMDA antagonist. Results show that acamprosate (170 and 320 mg kg-1 i.p.) produced a slight, and not significant, shift to the left of generalization curves of both morphine and amphetamine without affecting response rates. In contrast, MK-801 potentiated response rate effects of both morphine and amphetamine without affecting their generalization curves. As far as discriminative stimuli participate in the relapsing process of addiction, our results do not predict a role of acamprosate in the prevention of amphetamine or morphine abuse relapsing.

KW - Acamprosate

KW - D-amphetamins

KW - Drug-discrimination

KW - Morphine

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0032824985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032824985&partnerID=8YFLogxK

U2 - 10.1006/phrs.1999.0524

DO - 10.1006/phrs.1999.0524

M3 - Article

C2 - 10527645

AN - SCOPUS:0032824985

VL - 40

SP - 333

EP - 338

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 4

ER -